EXELIXIS INC's ticker is EXEL and the CUSIP is 30161Q104. A total of 340 filers reported holding EXELIXIS INC in Q2 2021. The put-call ratio across all filers is 1.12 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,311 | +14.3% | 60 | 0.0% | 0.00% | – |
| Q2 2023 | $1,147 | -1.5% | 60 | 0.0% | 0.00% | – |
| Q1 2023 | $1,165 | +21.1% | 60 | 0.0% | 0.00% | – |
| Q4 2022 | $962 | -3.8% | 60 | 0.0% | 0.00% | – |
| Q3 2022 | $1,000 | 0.0% | 60 | 0.0% | 0.00% | – |
| Q2 2022 | $1,000 | 0.0% | 60 | 0.0% | 0.00% | – |
| Q1 2022 | $1,000 | 0.0% | 60 | 0.0% | 0.00% | – |
| Q4 2021 | $1,000 | 0.0% | 60 | 0.0% | 0.00% | – |
| Q3 2021 | $1,000 | 0.0% | 60 | 0.0% | 0.00% | – |
| Q2 2021 | $1,000 | 0.0% | 60 | 0.0% | 0.00% | – |
| Q1 2021 | $1,000 | 0.0% | 60 | 0.0% | 0.00% | – |
| Q4 2020 | $1,000 | 0.0% | 60 | +53.8% | 0.00% | – |
| Q3 2020 | $1,000 | -97.4% | 39 | -99.6% | 0.00% | -100.0% |
| Q1 2014 | $39,000 | -41.8% | 11,000 | 0.0% | 0.01% | -46.7% |
| Q4 2013 | $67,000 | +4.7% | 11,000 | 0.0% | 0.02% | -11.8% |
| Q3 2013 | $64,000 | +28.0% | 11,000 | 0.0% | 0.02% | +30.8% |
| Q2 2013 | $50,000 | – | 11,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 15,001,073 | $199,507,000 | 56.91% |
| Sargent Investment Group, LLC | 1,032,560 | $18,193,000 | 3.40% |
| Bellevue Group AG | 3,930,700 | $69,259,000 | 1.10% |
| CAPITAL MANAGEMENT CORP /VA | 231,880 | $4,086,000 | 1.04% |
| Orbimed Advisors | 3,753,700 | $66,140,000 | 0.94% |
| TEALWOOD ASSET MANAGEMENT INC | 121,848 | $2,147,000 | 0.90% |
| FARALLON CAPITAL MANAGEMENT LLC | 7,500,000 | $132,150,000 | 0.89% |
| Chicago Capital, LLC | 806,113 | $14,204,000 | 0.87% |
| Penn Capital Management Company, LLC | 456,587 | $8,045,000 | 0.84% |
| AJO, LP | 7,636,882 | $134,561,000 | 0.80% |